In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Honey's provenance and authenticity has long been a sticky business, with claims difficult to prove and test for. As demand for cleaner labels drives its popularity, how are producers proving their ...

Prop firms offer traders access to capital, but not all firms treat their traders fairly. The difference between a good firm and a bad one often comes down to the rules, fees, and conditions that ...